Quantitative Analysis of the Impact of Total Ischemic Time on Myocardial Perfusion and Clinical Outcome in Patients With ST-Elevation Myocardial Infarction

被引:23
作者
Fokkema, Marieke L. [1 ]
Wieringa, Wouter G. [1 ]
van der Horst, Iwan C. [1 ]
Boersma, Eric [2 ]
Zijlstra, Felix [2 ]
de Smet, Bart J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Thoraxctr, Dept Cardiol, Groningen, Netherlands
[2] Erasmus MC, Thoraxctr, Dept Clin Epidemiol, Rotterdam, Netherlands
关键词
PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; REPERFUSION; CLOPIDOGREL; ABCIXIMAB; SIZE; METAANALYSIS; MORTALITY; OCCLUSION; THROMBUS;
D O I
10.1016/j.amjcard.2011.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early reperfusion of the infarct-related coronary artery is an important issue in improvement of outcomes after ST-segment elevation myocardial infarction (STEM!). In this study, the clinical significance of total ischemic time on myocardial reperfusion and clinical outcomes was evaluated in patients with STEMI treated with primary percutaneous coronary intervention and thrombus aspiration and additional triple-antiplatelet therapy. Total ischemic time was defined as time from symptom onset to first intracoronary therapy (first balloon inflation or thrombus aspiration). All patients with STEMI treated with primary percutaneous coronary intervention with total ischemic times >= 30 minutes and <24 hours from 2005 to 2008 were selected. Ischemic times were available in 1,383 patients, of whom 18.4% presented with total ischemic times <= 2 hours, 31.2% >2 to 3 hours, 26.8% >3 to 5 hours, and 23.5% >5 hours. Increased ischemic time was associated with age, female gender, hypertension, and diabetes. Patients with total ischemic times <5 hours more often had myocardial blush grade 3 (40% to 45% vs 22%, p <0.001) and complete ST-segment resolution (55% to 60% vs 42%, p = 0.002) than their counterparts with total ischemic times >5 hours. In addition, patients with total ischemic times <= 5 hours had lower 30-day mortality (1.5% vs 4.0%, p = 0.032) than patients with total ischemic times >5 hours. In conclusion, in this contemporary cohort of patients with STEMI treated with primary percutaneous coronary intervention, triple-antiplatelet therapy, and thrombus aspiration, short ischemic time was associated with better myocardial reperfusion and decreased mortality. After a 5-hour period in which outcomes remain relatively stable, myocardial reperfusion becomes suboptimal and mortality increases. (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;108:1536-1541)
引用
收藏
页码:1536 / 1541
页数:6
相关论文
共 29 条
  • [1] A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction
    Antoniucci, D
    Rodriguez, A
    Hempel, A
    Valenti, R
    Migliorini, A
    Vigo, F
    Parodi, G
    Fernandez-Pereira, C
    Moschi, G
    Bartorelli, A
    Santoro, GM
    Bolognese, L
    Colombo, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (11) : 1879 - 1885
  • [2] Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients
    Boersma, E
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (07) : 779 - 788
  • [3] Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
    Boersma, E
    Maas, ACP
    Deckers, JW
    Simoons, ML
    [J]. LANCET, 1996, 348 (9030) : 771 - 775
  • [4] Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction
    Brodie, BR
    Stuckey, TD
    Wall, TC
    Kissling, G
    Hansen, CJ
    Muncy, DB
    Weintraub, RA
    Kelly, TA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) : 1312 - 1319
  • [5] Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD trial)
    Brodie, Bruce R.
    Webb, John
    Cox, David A.
    Qureshi, Mansoor
    Kalynych, Anna
    Turco, Mark
    Schultheiss, Heinz P.
    Dulas, Daniel
    Rutherford, Barry
    Antoniucci, David
    Stuckey, Tom
    Krucoff, Mitch
    Gibbons, Raymond
    Lansky, Alexandra
    Na, Yingbo
    Mehran, Roxana
    Stone, Gregg W.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12) : 1680 - 1686
  • [6] Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction - A meta-analysis of randomized trials
    De Luca, G
    Suryapranata, H
    Stone, GW
    Antoniucci, D
    Tcheng, JE
    Neumann, FJ
    Van de Werf, F
    Antman, EM
    Topol, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14): : 1759 - 1765
  • [7] Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty
    De Luca, G
    van't Hof, AWJ
    de Boer, MJ
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    Zijlstra, F
    Suryapranata, H
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (12) : 1009 - 1013
  • [8] Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty
    De Luca, G
    Suryapranata, H
    Zijlstra, F
    van't Hof, AWJ
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JH
    de Boer, MJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (06) : 991 - 997
  • [9] Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials
    De Luca, Giuseppe
    Dudek, Dariusz
    Sardella, Gennaro
    Marino, Paolo
    Chevalier, Bernard
    Zijlstra, Felix
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (24) : 3002 - 3010
  • [10] Pathology of coronary microembolisation and no reflow
    Falk, E
    Thuesen, L
    [J]. HEART, 2003, 89 (09) : 983 - 985